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Intact cNOS-NO-cGMP Pathway in the Failing Human
Heart
We previously have shown that the angiotensin II receptor. type 1a (ATlaR)
message transiently decreases during ang II stimulation of cultured rat aor-
tic vascular smooth muscle cells (VSMC); and, it has been previously re-
ported by others that the mechanism of this decrease in cultured kidney
cells is through cAM P dependent pathways. In this study we examined the
signal transduction pathway of this regUlation in quiescent VSMC. Total cel-
lular RNA was harvested after time course exposure to reagents, Northern
blotted and probed. AT1aR message abundance decreased beginning two
hours after exposure to ang II (10 nM) and reached a minimum at 4 hours
after stimulation of 25% of baseline level. The protein kinase C (PKC) stimula-
tor, PMA (50 nM), caused a decrease in ATlaR message level with the same
time course and to the same extent as ang II. Downregulation of PKC with 24
hour prior exposure to PDBU (500 nM) blocked the decrease in AT1aR mes-
sage caused by PMA. However, pretreatment with either PDBU orthe potent
PKC inhibitor calphostin C (50 nM) did not block the decrease of AT1aR mes-
sage level caused by ang II. In contrast. stimulation of cAMP with forskolin
(50 mM). cholera toxin (1 ang/ml) or the soluble analog 8-bromocyclic AM P(1
CMEC and in ARVM in a dose dependent manner that was maximal 4-8
hours after treatment. This effect of All was abolished after coincubation
with the angiotensin II receptor antagonist (AT-1) losartan (10-6 M), and the
ET-1 response was inhibited by the peptide endothelin type A (ETA) antago-
nist BO-123 (10-6 M). To determine whether bFGF itself autoregulates bFGF
mRNA abundance, ARVM and CMEC were treated with rh bFGF (20ng/mll. A
ninefold increase in bFGF mRNA was detected, thus indicating positive au-
toregulation. A marked induction of atrial natriuretic peptide mRNA, known
as a molecular marker of phenotype dedifferentiation in hypertrophy, was
observed after 24 and 48 hrs incubation with rh bFGF in ARVM. Finally, the
inflammatory cytokine interleukin 113 (rh IL-1f3) upregulates bFGF gene ex-
pression in ARVM, a response that could be amplified by interferon y (rm
IFN-y).
Thus, bFGF gene expression in ARVM and CMEC from rat heart is regu-
lated by All and ET-1 through the AT-1 receptor and (ETA) receptor subtypes.
The upregulation of bFGF gene transcription in response to various stimuli
known to affect myocyte and endothelial growth suggest a role for bFGF as a
signalling peptide in the hypertrophic response of adult ventricular myocytes
and cardiac microvascular endothelial cells.
Chi-Ming Wei. John Lust. Zvonimir Katusic. Michihisa Jougasaki, Denise Heublein,
Sharon Sandberg. Debra Lewis, Virginia Miller, Christopher McGregor,
John Burnett. Jr. Mayo Clinic, Rochester, MN
Nitric oxide (NO) is a potent endothelium-derived relaxing factor which also
may modulate cardiac myocyte inotropism and growth via increases in
cGMP. While both the constitutive (cNOS) and inducible (iNOS)forms of nitric
oxide synthase have been detected in mammalian hearts, the overall pres-
ence and activity of the cNOS-NO-cGMP pathway in the normal and failing
human heart remains poorly defined. The present studies were designed to
investigate the cNOS-NO-cGMP pathway in normal and failing human atrial
and ventricular myocardium and to determine plasma NO and cGMP in the
presence and absence of CHE Myocardial tissue and plasma were obtained
from five end-stage heart failure patients undergoing cardiac transplantation
and five cardiac donors. Normal plasma NO and cGMP were also determined
in normal humans without disease. cNOS production and localization were
determined utilizing Northern blot analysis, in situ hybridization and immuno-
histochemistry with probes for endothelial-NOS and brain-NOS. Plasma and
tissue NO were measured by nitrate determination utilizing chemilumines-
cence. Northern blot analysis and in situ demonstrated cNOS to be present
and localized to atrial and ventricular myocytes in equal concentrations and
distributions in normal and failing hearts. Tissue NO as determined by nitrate
concentration was detectable and equal in normal and failing hearts while
plasma NO concentration tended to be increased in CHF patients. Cardiac
tissue cGMP paralleled tissue NO, although, plasma cGMP concentration
was significantly increased in CHF patients compared with normal subjects.
The present studies demonstrate that cNOS mRNA and cNOS protein are
present in the normal human heart and this cNOS-NO-cGMP pathway is pre-
served in the failing human heart. These studies suggest that this paracrine
and autocrine pathway may continue to function in the control of myocardial
function in the failing human myocardium.
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Mechanism of Decrease of Angiotensin II Receptor
Message Through Dual Signal Transduction
Pathways in Vascular Smooth Muscle
Stanley A. Rubin, Tim Bui, Lee Carter VA Medical Center, Long Beach and University
of California, Irvine, CA
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Anna Y. Hsu, Judith L. Swain University ofPennsylvania. Philadelphia. PA
Fibroblast growth factors (FGFs) have been demonstrated to regulate myo-
genic differentiation. Recently, forms of FGF have been generated that reside
in the cytoplasm and appear to be biologically active. suggesting that an in-
tracellular form of FGF may be able to transduce its signal through signaling
pathways independent of its interaction with cell surface (transmembrane)
FGF receptors (FGFR). We report in this study a potential mechanism by
which such signaling can be modulated by an intracellular form of the recep-
tor (I-FGFR). To generate this form of the receptor, the cDNA encoding the 2
IgG-like domain form of the murine transmembrane FGFR was mutated to re-
move its signal sequence and acidic box by PCR mutagenesis. This construct
was then epitope-tagged to allow it to be distinguished from the endogenous
surface FGF receptor. When the I-FGFR was transientlytransfected into COS
cells, a diffuse and reticular pattern was observed by indirect immunofluo-
rescence microscopy, indicating cytoplasmic localization with association to
organized intracellular structures, such as cytoskeleton or organellar mem-
brane. To test for the biologic effect of the I-FGFR, stable cell lines containing
the I-FGFR were generated in Sol 8 cells. Quadruplicate samples of four cell
lines expressing high levels of the I-FGFR, and four control cell lines trans-
fected with vector alone, were grown in mitogen poor medium (5% horse
serum). Their ability to differentiate was assessed by their levels of creatine
kinase activity normalized to total soluble protein (nmol NADPH/min/mg pro-
tein):
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Constitutive Expression of an Intracellular Form of
Fibroblast Growth Factor Receptor Triggers
Myogenic Differentiation
The results demonstrate that the intracellular form of the FGF receptor lo-
calizes to the cytoplasm of myocytes, and the increased expression of this
receptor isoform triggers myogenic differentiation. We propose that this re-
ceptor promotes differentiation by binding endogenous FGF, and thus inhibit-
ing the activity of FGF that normally preserves the undifferentiated state. The
ability to generate and express the intracellular FGF receptor, therefore, may
be a generally useful method of modulating FGF dependent regulation of
proliferation and differentiation of other cell types such as smooth muscle
and transformed cells.
The down-regulation of 131 AR and AT1 receptors was significantly related
(r = 0.62, n = 12, P < 0.05)
Conclusions: (1) Compared to 13 adrenergic receptors ang II receptors are
very low density in the human heart. (2) The AT1 receptor sUbtype predomi-
nates in the nonfailing human heart. (3) ATl but not AT2 receptors are down-
regulated in failing heart. (4) Down-regulation of Ang-II AT1 receptor is similar
in degree to down-regulation of 131-adrenergic receptors. These data suggest
that the AT1 and 131 receptors are respectively exposed to increased concen-
trations of mutually activatedlinduced norepinephrine and Ang-II in the failing
human heart.
Basic fibroblast growth factor (bFGF) has been shown to stimulate protein
synthesis in adult rat ventricular myocytes (ARVM) and DNA synthesis in mi-
crovascular endothelial cells (CM EC). To determine whether Angiotensin 11
(All) and Endothelin I (ET-1), known as peptides affecting myocyte growth,
regulate bFGF gene expression in the myocardium we examined the effects
of these two peptide autacoids on bFGF mRNA abundance in both cardiac
cell types. Baseline levels for bFGF mRNA in freshly isolated ARVM were
4 to 5 fold lower than in CMEC in RNase protection assays. All (10-6 -
10-8 M) and ET-1 (10-8 - 10-10 M) increased bFGF mRNA abundance in
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Regulation of Basic Fibroblast Growth Factor Gene
Expression in Rat Cardiac Microvascular Endothelial
Cells and Adult Ventricular Myocytes
Thomas A. Fischer. Krishna Singh, Alborz Alali, Min-Ae Lee, David Kaye. Albert
p. Gatbut. Jean Luc Balligand, Ralph A. Kelly, Thomas W. Smith Cardiovascular
Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical
School, Boston, MA
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mM) did not decrease AT1aR message level. whereas inhibition of PKA with
H-8 pretreatment (10 mM) followed by ang II still decreased AT1aR message
abundance. We conclude that the decrease of AT1aRmessage level in VSMC
is through both PKC and non-PKC dependent pathways, but not through PKA
or cAMP dependent pathways.
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Myocardial Adenylyl Cyclase Activity in an Animal
Model of Dilated Cardiomyopathy Treated
Chronically with the Non-Selective P-blocker
Carteolol
Farid Khan, Roger J. Hajjar, Ronglih Liao, Farid Fuleihan, Michael Bristow, Judith
K. Gwathmey Harvard Medical School Boslon, MA; University of Colorado, Denver, Co
It has been shown that heart failure is associated with a decrease in fJ,-
receptor density and uncoupling of adenylyl cyclase (AC). Treatment with {J-
blockade increases {J-receptors but it is not known whether adenylyl cyclase
activity temporally follows {J1-receptor upregulation. We have previously
shown that chronic {J-blockade with carteolol (CAR) improves survival and
left ventricular (LV) function in turkeys with furazolidone-induced dilated car-
diomyopathy (DCM). We measured adenylyl cyclase activity in hearts from
control (CON). DCM, carteolol-treated (10 mglkgfdx28 days) CON (CONCAR '
and carteolol-treated (10 mglkg/dx28 days) DCM (DCMCAR) animals. AC ac-
tivitywas measured as cAMP (pmollmg/min) and is given in the table below:
Basal Gpp(NH)p NaF ISO FORSKOLIN
patent veins and no evidence of perforation after ablation and at 6 days in all
14 dogs. Segmental necrosis of the adventitia and media (but not intima) of
the LCx coronary artery (bold arrow) was present in 8/18 lesions of 66 V and
0/1 0 at 50\1.
Conclusions: Electrode cooling by saline irrigation allows high power (66
V, 45 W) RF application in the CS and venous branches, producing lesions
likely to ablate epicardial left free-wall and posteroseptal AP The significance
of segmental medical necrosis (normal intima) of LCx is unknown.
Conclusions: 1) Improvement in LV function is not accompanied temporally
by an increase in AC activity, 2} Restoration of coupling between AC and G-
protein does not seem to be a necessary step to provide improvement in
cardiac function in this animal model of heart failure.
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1777-1 I Effective Delivery of Radlofrequency Energy Through
the Coronary Sinus without Impedance Rise Using a
Saline Irrigated Electrode
Impedance rise occurred with electrode temperature <40 'C and an audi-
ble pop and no thrombus formation. Lesions involving the epicardial surface
of both the left atrium and ventricle (Fig) were found in 17/18 sites at 66 V but
only 1110 sites at 50\1. Necrosis did not extend to the endocardium at any of
the 28 sites, eliminating risk of thromboembolism. CS angiography showed
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J. Marcus Wharton, Carleton Nibley, Carole M. Sykes, Reed Rowan,
Glen McLaughlin, Troy Chapman, Philip E. Oyer 1 Duke University Medical Center,
Durham, NC: 1 Stanford University, Stanford, CA
Tissue heating and lesion formation during high power radiofrequency (RF)
current ablation are limited by abrupt impedance rise when electrode tip tem-
peratures exceed 100'C. Electrode tip chilling by continuous intra-electrode
saline infusion has allowed use of higher power while delaying or preventing
impedance limitation, thus creating larger lesions. Neither a dose-response
relationship nor size limit for lesions produced in this manner have been es-
tablished. Twelve sheep (mean wI. 65 kg) received chilled RF ablation at up
to 8 separate LV sites. High power RF current of 40, 50, 60 or 70W was de-
livered via modified 7Fr deflectable catheter with a 4 mm tip through which
saline 126'C) was continuously infused at 0.6 ml/sec. RF current duration
Electrode tip temperature monitoring during standard radiofrequency (RF)
current catheter ablation can be used to prevent abrupt impedance rise (IR)
associated with tip temperatures> 1OO'C. Electrode tip chilling during RF
ablation by intraelectrode saline infusion can also reduce the likelihood of
abrupt IR and allow larger lesion formation. However, both the utility of tip
temperature monitoring during tip chilling and the registered tip temperature
associated with IR are unknown.
Methods: Twelve sheep (mean wt. 65 kg) received chilled RF ablation at up
to 8 separate LV sites. High power RF current of 40, 50, 60 or 70W was de-
livered via modified 7Fr deflectable catheter with a 4 mm tip through which
saline 126'C) was continuously infused at 0.6 mllsec. RF current duration was
60 seconds or until IR occurred. Tip temperature was continuously moni-
tored by electrode tip thermocouple.
Results: A total of 95 applications of RF current were analyzed, of which
40 resulted in an abrupt IR. The frequency of IR increased with higher power
applications (40W-8.3%, 50W-23%, 60W-63%, 70W-71 %). Abrupt IR was ob-
served at a mean temperature of 75.0 ± 11.8'C (range 44.4 to 94.7'C). This
temperature was significantly higher than for RF applications not associated
with IR (49.8 ± 8.3'C; P < 0.001). An abrupt IR was observed in all cases
with tip temperature 2:67'C (N = 32). Audible "popping" emanating from the
catheter tip occurred during 20 RF current applications, and most (90%) were
associated with abrupt IR.
Conclusion: Electrode tip temperature monitoring is useful during chilled-
tip RF ablation, but the thermocouple registers a lower temperature at the
time of impedance rise compared to traditional RF ablation.
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1777-31 Establishment of a Dose-Response Relationship for
High Power Chilled-Tip Radiofrequency Current
Ablation in Sheep
1777-21 Predictors of Abrupt Impedance Rise During
Chilled-Tip Radiofrequency Catheter Ablation
Carleton Nibler Carole M. Sykes, Reed Rowan, Troy Chapman, Glen McLaughlin,
Philip E. Oyer ,J. Marcus Wharton. Duke University Medical Center, Durham, NC,'
1 Stanford University, Stanford, CA
Elect Temp lOG) Lesion Diameter (mm)
31 ± 3 2.8 ± 08
34 ± 5 7.6 ± 1.4
Voltage (V) Power (WI Imp Rise
CON 6.7±1.4 17.7±2.5 19.7±43 103±0.9 78.1±8.7
CONCAR 2.7 ± 0.4' 8.0 ± 1.5' 17.2 ± 1.0' 6.4 ± 1.0' 52.0 ± 3.0'
DCM 4.7 ± 0.7' 8.5 ± 1.0' 24.1 ± 2.7' 6.4 ± 0.7' 60.9 ± 55'
DCMCAR 2.8 ± 0.5'# 4.6 ± 4.3'# 18.5 ± 1.7'# 4.9 ± 0.6'# 36.9 ± 2.9'#
Results: MEAN ± SEM, n = 3 for all groups, ISO = isoproterenol, NaF ~ Sodium Fluoride.
'p < 0.01 compared to CON; # P< 0.01 compared to DCM
Hiroshi Nakagawa, William S. Yamanashi, Jan V Pitha, Khek C. Yong,
Mauricio Arruda, Michael Rome, Xanzhang Wang, Ken-ichiro Ohtomo,
Ralph Lazzara, Warren M. Jackman University of Oklahoma and DVAMC, Oklahoma
City, OK
Some left free-wall and posteroseptal accessory pathways (AP) are located
relatively close to the coronary sinus (CS) or its branches. Limitations of ab-
lation from the venous system include rapid occurrence of an impedance
rise at low power and the risk of perforation, due to high electrode tem-
perature. We hypothesized that saline irrigation through the ablation elec-
trode will maintain a low electrode temperature and allow safe application
of higher RF power. In 14 dogs (18-22 kg), a 7F deflectable catheter with
a lumen and a 5 mm tip electrode containing a thermistor and 6 irrigation
holes was inserted into the CS. During saline irrigation (60 mllmin). two RF
applications were delivered for 60 seconds or until an impedance rise. One
application was placed in lateral-anterolateral CS and one was placed in the
orifice or proximal segment of the middle cardiac vein. CS angiography was
performed before and immediately after ablation and 6 days later (just before
sacrifice).
10 50 24±3 0/10
18 66 45 ± 5 3/18
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